Tampa Biopharma Firm Makes Gains in the Expanding Medical Marijuana Industry
Tampa biopharmaceutical firm has been awarded the first U.S. patent for a commercial process that could lead to additional medical therapies based on substances unique to marijuana.
The company, formerly CBC Biotechnologies Inc., has changed its name to Teewinot Life Sciences Corp., and struck a deal with a contract research organization to scale up its proprietary processes, a press release said.
The changes follow a $7 million venture capital investment in CBC in March.
There’s a $5.4 billion market for medical marijuana, according to Greenspoon Marder, a Fort Lauderdale-based law firm with an office in Tampa. The law firm just expanded its regulated industries practice to include cannabis law, it announced on June 6.
Teewinot was awarded a patent covering a commercial process for biosynthetic production of the cannabinoids THCA, CBDA and CBCA, the press release said.
The patent is owned by Full Spectrum Laboratories, Teewinot’s wholly...
This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.
Follow us on Instagram
Connect with us on Linkedin